WHITEHAWK THERAPEUTICS INC (WHWK) Stock Fundamental Analysis

NASDAQ:WHWK • US00032Q1040

3 USD
-0.05 (-1.64%)
Last: Feb 23, 2026, 05:20 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

WHWK gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 521 industry peers in the Biotechnology industry. WHWK has a great financial health rating, but its profitability evaluates not so good. WHWK is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year WHWK has reported negative net income.
  • WHWK had a negative operating cash flow in the past year.
  • In the past 5 years WHWK always reported negative net income.
  • WHWK had a negative operating cash flow in each of the past 5 years.
WHWK Yearly Net Income VS EBIT VS OCF VS FCFWHWK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -9.35%, WHWK belongs to the top of the industry, outperforming 84.84% of the companies in the same industry.
  • WHWK has a better Return On Equity (-9.94%) than 87.91% of its industry peers.
Industry RankSector Rank
ROA -9.35%
ROE -9.94%
ROIC N/A
ROA(3y)-57.7%
ROA(5y)-50.49%
ROE(3y)-74.03%
ROE(5y)-62.56%
ROIC(3y)N/A
ROIC(5y)N/A
WHWK Yearly ROA, ROE, ROICWHWK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5K 10K

1.3 Margins

  • WHWK's Gross Margin of 89.22% is amongst the best of the industry. WHWK outperforms 91.36% of its industry peers.
  • The Profit Margin and Operating Margin are not available for WHWK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 89.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
WHWK Yearly Profit, Operating, Gross MarginsWHWK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • WHWK does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for WHWK has been increased compared to 1 year ago.
  • Compared to 5 years ago, WHWK has more shares outstanding
  • There is no outstanding debt for WHWK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
WHWK Yearly Shares OutstandingWHWK Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
WHWK Yearly Total Debt VS Total AssetsWHWK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • An Altman-Z score of 5.05 indicates that WHWK is not in any danger for bankruptcy at the moment.
  • WHWK's Altman-Z score of 5.05 is fine compared to the rest of the industry. WHWK outperforms 72.94% of its industry peers.
  • There is no outstanding debt for WHWK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 5.05
ROIC/WACCN/A
WACC8.72%
WHWK Yearly LT Debt VS Equity VS FCFWHWK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

  • WHWK has a Current Ratio of 16.76. This indicates that WHWK is financially healthy and has no problem in meeting its short term obligations.
  • WHWK's Current ratio of 16.76 is amongst the best of the industry. WHWK outperforms 93.28% of its industry peers.
  • WHWK has a Quick Ratio of 16.76. This indicates that WHWK is financially healthy and has no problem in meeting its short term obligations.
  • WHWK has a Quick ratio of 16.76. This is amongst the best in the industry. WHWK outperforms 93.28% of its industry peers.
Industry RankSector Rank
Current Ratio 16.76
Quick Ratio 16.76
WHWK Yearly Current Assets VS Current LiabilitesWHWK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • WHWK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.65%, which is quite good.
  • The Revenue for WHWK has decreased by -42.62% in the past year. This is quite bad
  • Measured over the past years, WHWK shows a very strong growth in Revenue. The Revenue has been growing by 185.21% on average per year.
EPS 1Y (TTM)9.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.48%
Revenue 1Y (TTM)-42.62%
Revenue growth 3Y185.21%
Revenue growth 5YN/A
Sales Q2Q%-100%

3.2 Future

  • WHWK is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.78% yearly.
  • WHWK is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -14.87% yearly.
EPS Next Y88.14%
EPS Next 2Y19.73%
EPS Next 3Y12.78%
EPS Next 5YN/A
Revenue Next Year-72.66%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y-14.87%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
WHWK Yearly Revenue VS EstimatesWHWK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2020 2021 2022 2023 2024 2025 2031 2032 2033 20M 40M 60M 80M 100M
WHWK Yearly EPS VS EstimatesWHWK Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -2 -4 -6 -8

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • WHWK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for WHWK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WHWK Price Earnings VS Forward Price EarningsWHWK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
WHWK Per share dataWHWK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2 3

4.3 Compensation for Growth

  • WHWK's earnings are expected to grow with 12.78% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.73%
EPS Next 3Y12.78%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • WHWK does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

WHITEHAWK THERAPEUTICS INC

NASDAQ:WHWK (2/23/2026, 5:20:02 PM)

3

-0.05 (-1.64%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-06
Earnings (Next)03-12
Inst Owners58.42%
Inst Owner ChangeN/A
Ins Owners12.42%
Ins Owner ChangeN/A
Market Cap141.39M
Revenue(TTM)14.38M
Net Income(TTM)-15.62M
Analysts76
Price Target4.59 (53%)
Short Float %2.28%
Short Ratio6.15
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-366.68%
Min EPS beat(2)-482.33%
Max EPS beat(2)-251.03%
EPS beat(4)1
Avg EPS beat(4)-227.7%
Min EPS beat(4)-482.33%
Max EPS beat(4)21.14%
EPS beat(8)4
Avg EPS beat(8)-110.08%
EPS beat(12)7
Avg EPS beat(12)-69.58%
EPS beat(16)10
Avg EPS beat(16)-50.39%
Revenue beat(2)0
Avg Revenue beat(2)-100%
Min Revenue beat(2)-100%
Max Revenue beat(2)-100%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)125%
EPS NQ rev (1m)-23.2%
EPS NQ rev (3m)70.57%
EPS NY rev (1m)0%
EPS NY rev (3m)64.04%
Revenue NQ rev (1m)-20%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.85%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 9.83
P/FCF N/A
P/OCF N/A
P/B 0.9
P/tB 0.9
EV/EBITDA N/A
EPS(TTM)-2.06
EYN/A
EPS(NY)-1.33
Fwd EYN/A
FCF(TTM)-2.04
FCFYN/A
OCF(TTM)-2.02
OCFYN/A
SpS0.31
BVpS3.33
TBVpS3.33
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -9.35%
ROE -9.94%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 89.22%
FCFM N/A
ROA(3y)-57.7%
ROA(5y)-50.49%
ROE(3y)-74.03%
ROE(5y)-62.56%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 590.4%
Cap/Sales 5.13%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 16.76
Quick Ratio 16.76
Altman-Z 5.05
F-Score4
WACC8.72%
ROIC/WACCN/A
Cap/Depr(3y)1160.76%
Cap/Depr(5y)712.22%
Cap/Sales(3y)8.52%
Cap/Sales(5y)6.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)9.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.48%
EPS Next Y88.14%
EPS Next 2Y19.73%
EPS Next 3Y12.78%
EPS Next 5YN/A
Revenue 1Y (TTM)-42.62%
Revenue growth 3Y185.21%
Revenue growth 5YN/A
Sales Q2Q%-100%
Revenue Next Year-72.66%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y-14.87%
EBIT growth 1Y-70.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-48.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-55.31%
OCF growth 3YN/A
OCF growth 5YN/A

WHITEHAWK THERAPEUTICS INC / WHWK FAQ

What is the fundamental rating for WHWK stock?

ChartMill assigns a fundamental rating of 4 / 10 to WHWK.


What is the valuation status of WHITEHAWK THERAPEUTICS INC (WHWK) stock?

ChartMill assigns a valuation rating of 0 / 10 to WHITEHAWK THERAPEUTICS INC (WHWK). This can be considered as Overvalued.


How profitable is WHITEHAWK THERAPEUTICS INC (WHWK) stock?

WHITEHAWK THERAPEUTICS INC (WHWK) has a profitability rating of 2 / 10.


What is the expected EPS growth for WHITEHAWK THERAPEUTICS INC (WHWK) stock?

The Earnings per Share (EPS) of WHITEHAWK THERAPEUTICS INC (WHWK) is expected to grow by 88.14% in the next year.